Quarter Financials

Fate Therapeutics, Inc. (FATE)

$19.83

+0.18 (+0.92%)
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers are in thousands

Retained Earning Schedule

Year 2022 Q3 2022 Q2 2022 Q1 2021 Q4 2021 Q3 2021 Q2 2021 Q1 2020 Q4
Net Income -84-76-66-69-43-55-45-53
Dividend Paid --------
Retained Earnings -994-911-835-769-700-657-602-557

PPE Schedule

Year 2022 Q3 2022 Q2 2022 Q1 2021 Q4 2021 Q3 2021 Q2 2021 Q1 2020 Q4
Capital Expenditure -9-10-10-18-15-14-4-2
Net PPE 17617216716214012511599

Intangible and Goodwill Schedule

Year 2022 Q3 2022 Q2 2022 Q1 2021 Q4 2021 Q3 2021 Q2 2021 Q1 2020 Q4
New Purchases -185-530-99-165-173-132-64-102
Intangible and Goodwill --------